Skip to main content

Advertisement

SpringerLink
Log in

Immunology Updates in Recurrent Implantation Failure in In Vitro Fertilization

  • REVIEW
  • Published:
Current Obstetrics and Gynecology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

To summarize standards and recent advances in the understanding of immunology in recurrent implantation failure in IVF.

Recent Findings

Recent consensus groups have put forth recommendations regarding the criteria for RIF. The focus of recent studies in RIF has shifted to more nuanced relationships of immunologic dysfunction at the maternal/fetal interface rather than systemic peripheral sources. Recent areas of novel therapy investigation include intrauterine PMBCs, PRP, and GCSF. Accumulating data on chronic endometritis suggests it may be associated with recurrent implantation failure and treatment may improve reproductive outcomes.

Summary

RIF remains a frustrating and elusive diagnosis for patients and clinicians. In the era of improved IVF protocols and genetic screening, the true incidence of RIF is likely quite low. New recommendations for a consensus diagnosis for RIF may improve the generalizability of future studies. The contribution of immunologic factors in RIF has long been a focus of investigation, and prior therapies have focused on systemic immune suppression, without clear improvement in pregnancy rate and at high cost to patients. More recent studies have identified immune profiles at the maternal/fetal interface that may provide avenues for more targeted and effective therapies. Intrauterine PMBCs, PRP, and subcutaneous GCSF may offer some benefit in improving implantation rate, although data is preliminary and not yet proven for clinical practice. Chronic endometritis remains a potential contributor to RIF, although treatment and/or cure and its relationship to improved live birth rates remain debatable. Unproven therapies should continue to be avoided in this population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: •  Of importance •• Of major importance

  1. • Franasiak JM, Alecsandru D, Forman EJ, Gemmell LC, Goldberg JM, Llarena N, et al. A review of the pathophysiology of recurrent implantation failure. Fertil Steril. 2021;116(6):1436–48. Recent review of potential mechanisms behind recurrent implantation failure.

    Article  PubMed  Google Scholar 

  2. Mukherjee N, Sharma R, Modi D. Immune alterations in recurrent implantation failure. Am J Reprod Immunol. 2023;89(2):e13563.

    Article  CAS  PubMed  Google Scholar 

  3. Prevention CfDCa. ART Success Rates. [2020]. [updated February 21, 2023]. Available from: https://www.cdc.gov/art/artdata/index.html.

  4. Pirtea P, Cedars MI, Devine K, Ata B, Franasiak J, Racowsky C, et al. Recurrent implantation failure (Rif): reality or a statistical mirage? Fertil Steril. 2023.

    PubMed  Google Scholar 

  5. Somigliana E, Busnelli A, Kalafat E, Vigano P, Ata B. Recurrent implantation failure: a plea for a widely adopted rational definition. Reprod Biomed Online. 2022;45(2):183–5.

    Article  PubMed  Google Scholar 

  6. Stern C, Chamley L, Hale L, Kloss M, Speirs A, Baker HW. Antibodies to beta2 glycoprotein I are associated with in vitro fertilization implantation failure as well as recurrent miscarriage: results of a prevalence study. Fertil Steril. 1998;70(5):938–44.

    Article  CAS  PubMed  Google Scholar 

  7. El-Toukhy T, Taranissi M. Towards better quality research in recurrent implantation failure: standardizing its definition is the first step. Reprod Biomed Online. 2006;12(3):383–5.

    Article  PubMed  Google Scholar 

  8. •• Pirtea P, Cedars MI, Devine K, Ata B, Franasiak J, Racowsky C, et al. (2023). Recurrent implantation failure: reality or a statistical mirage?: Consensus statement from the July 1, 2022 Lugano Workshop on recurrent implantation failure. Fertil Steril. 2023;120(1):45–59. Consensus review on most recent available literature on recurrent implantation failure from a panel of international experts.

    Google Scholar 

  9. •• ESHRE Working Group on Recurrent Implantation, et al. ESHRE good practice recommendations on recurrent implantation failure. Hum Reprod Open 2023;2023(3):hoad023. Practice recommendations from leaders in the field regarding currently available treatment options for recurrent implantation failure.

  10. Ledee N, Petitbarat M, Prat-Ellenberg L, Dray G, Cassuto GN, Chevrier L, et al. Endometrial immune profiling: a method to design personalized care in assisted reproductive medicine. Front Immunol. 2020;11:1032.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Pantazi A, Tzonis P, Perros G, Graphou O, Keramitsoglou T, Koussoulakos S, et al. Comparative analysis of peripheral natural killer cells in the two phases of the ovarian cycle. Am J Reprod Immunol. 2010;63(1):46–53.

    Article  CAS  PubMed  Google Scholar 

  12. Nishikawa K, Saito S, Morii T, Hamada K, Ako H, Narita N, et al. Accumulation of CD16-CD56+ natural killer cells with high affinity interleukin 2 receptors in human early pregnancy decidua. Int Immunol. 1991;3(8):743–50.

    Article  CAS  PubMed  Google Scholar 

  13. Sfakianoudis K, Rapani A, Grigoriadis S, Pantou A, Maziotis E, Kokkini G, et al. The role of uterine natural killer cells on recurrent miscarriage and recurrent implantation failure: from pathophysiology to treatment. Biomedicines. 2021;9(10).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Ledee-Bataille N, Bonnet-Chea K, Hosny G, Dubanchet S, Frydman R, Chaouat G. Role of the endometrial tripod interleukin-18, -15, and -12 in inadequate uterine receptivity in patients with a history of repeated in vitro fertilization-embryo transfer failure. Fertil Steril. 2005;83(3):598–605.

    Article  CAS  PubMed  Google Scholar 

  15. Laird SM, Tuckerman EM, Li TC. Cytokine expression in the endometrium of women with implantation failure and recurrent miscarriage. Reprod Biomed Online. 2006;13(1):13–23.

    Article  CAS  PubMed  Google Scholar 

  16. Von Woon E, Greer O, Shah N, Nikolaou D, Johnson M, Male V. Number and function of uterine natural killer cells in recurrent miscarriage and implantation failure: a systematic review and meta-analysis. Hum Reprod Update. 2022;28(4):548–82.

    Article  CAS  Google Scholar 

  17. Seshadri S, Sunkara SK. Natural killer cells in female infertility and recurrent miscarriage: a systematic review and meta-analysis. Hum Reprod Update. 2014;20(3):429–38.

    Article  PubMed  Google Scholar 

  18. Moffett A, Shreeve N. First do no harm: uterine natural killer (NK) cells in assisted reproduction. Hum Reprod. 2015;30(7):1519–25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Wong LF, Porter TF, Scott JR. Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev. 2014;2014(10):CD000112.

    PubMed  PubMed Central  Google Scholar 

  20. Diaz-Hernandez I, Alecsandru D, Garcia-Velasco JA, Dominguez F. Uterine natural killer cells: from foe to friend in reproduction. Hum Reprod Update. 2021;27(4):720–46.

    Article  CAS  PubMed  Google Scholar 

  21. Chazara O, Xiong S, Moffett A. Maternal KIR and fetal HLA-C: a fine balance. J Leukoc Biol. 2011;90(4):703–16.

    Article  CAS  PubMed  Google Scholar 

  22. Alecsandru D, Garcia-Velasco JA. Why natural killer cells are not enough: a further understanding of killer immunoglobulin-like receptor and human leukocyte antigen. Fertil Steril. 2017;107(6):1273–8.

    Article  CAS  PubMed  Google Scholar 

  23. Hiby SE, Apps R, Sharkey AM, Farrell LE, Gardner L, Mulder A, et al. Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2. J Clin Invest. 2010;120(11):4102–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Hiby SE, Apps R, Chazara O, Farrell LE, Magnus P, Trogstad L, et al. Maternal KIR in combination with paternal HLA-C2 regulate human birth weight. J Immunol. 2014;192(11):5069–73.

    Article  CAS  PubMed  Google Scholar 

  25. Hiby SE, Regan L, Lo W, Farrell L, Carrington M, Moffett A. Association of maternal killer-cell immunoglobulin-like receptors and parental HLA-C genotypes with recurrent miscarriage. Hum Reprod. 2008;23(4):972–6.

    Article  CAS  PubMed  Google Scholar 

  26. Hiby SE, Walker JJ, O’Shaughnessy KM, Redman CW, Carrington M, Trowsdale J, et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med. 2004;200(8):957–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Alecsandru D, Garrido N, Vicario JL, Barrio A, Aparicio P, Requena A, et al. Maternal KIR haplotype influences live birth rate after double embryo transfer in IVF cycles in patients with recurrent miscarriages and implantation failure. Hum Reprod. 2014;29(12):2637–43.

    Article  CAS  PubMed  Google Scholar 

  28. Franasiak JM, Scott RT. Contribution of immunology to implantation failure of euploid embryos. Fertil Steril. 2017;107(6):1279–83.

    Article  CAS  PubMed  Google Scholar 

  29. Del Prete G, Maggi E, Romagnani S. Human Th1 and Th2 cells: functional properties, mechanisms of regulation, and role in disease. Lab Invest. 1994;70(3):299–306.

    PubMed  Google Scholar 

  30. Stokkeland LMT, Giskeodegard GF, Stridsklev S, Ryan L, Steinkjer B, Tangeras LH, et al. Serum cytokine patterns in first half of pregnancy. Cytokine. 2019;119:188–96.

    Article  CAS  PubMed  Google Scholar 

  31. Kalu E, Bhaskaran S, Thum MY, Vishwanatha R, Croucher C, Sherriff E, et al. Serial estimation of Th1:th2 cytokines profile in women undergoing in-vitro fertilization-embryo transfer. Am J Reprod Immunol. 2008;59(3):206–11.

    Article  CAS  PubMed  Google Scholar 

  32. Galgani M, Insabato L, Cali G, Della Gatta AN, Mirra P, Papaccio F, et al. Regulatory T cells, inflammation, and endoplasmic reticulum stress in women with defective endometrial receptivity. Fertil Steril. 2015;103(6):1579–86 e1.

    Article  CAS  PubMed  Google Scholar 

  33. Kwak-Kim JY, Chung-Bang HS, Ng SC, Ntrivalas EI, Mangubat CP, Beaman KD, et al. Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF. Hum Reprod. 2003;18(4):767–73.

    Article  CAS  PubMed  Google Scholar 

  34. Park HJ, Kim YS, Yoon TK, Lee WS. Chronic endometritis and infertility. Clin Exp Reprod Med. 2016;43(4):185–92.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Vitagliano A, Saccardi C, Litta PS, Noventa M. Chronic endometritis: really so relevant in repeated IVF failure? Am J Reprod Immunol. 2017;78(6).

    Article  PubMed  Google Scholar 

  36. Greenwood SM, Moran JJ. Chronic endometritis: morphologic and clinical observations. Obstet Gynecol. 1981;58(2):176–84.

    CAS  PubMed  Google Scholar 

  37. Liu Y, Chen X, Huang J, Wang CC, Yu MY, Laird S, et al. Comparison of the prevalence of chronic endometritis as determined by means of different diagnostic methods in women with and without reproductive failure. Fertil Steril. 2018;109(5):832–9.

    Article  PubMed  Google Scholar 

  38. Song D, He Y, Wang Y, Liu Z, Xia E, Huang X, et al. Impact of antibiotic therapy on the rate of negative test results for chronic endometritis: a prospective randomized control trial. Fertil Steril. 2021;115(6):1549–56.

    Article  CAS  PubMed  Google Scholar 

  39. Vitagliano A, Saccardi C, Noventa M, Di Spiezio Sardo A, Saccone G, Cicinelli E, et al. Effects of chronic endometritis therapy on in vitro fertilization outcome in women with repeated implantation failure: A systematic review and meta-analysis. Fertil Steril. 2018;110(1):103–12 e1.

    Article  PubMed  Google Scholar 

  40. Kliman HJ, Frankfurter D. Clinical approach to recurrent implantation failure: evidence-based evaluation of the endometrium. Fertil Steril. 2019;111(4):618–28.

    Article  PubMed  Google Scholar 

  41. Diaz-Gimeno P, Horcajadas JA, Martinez-Conejero JA, Esteban FJ, Alama P, Pellicer A, et al. A genomic diagnostic tool for human endometrial receptivity based on the transcriptomic signature. Fertil Steril. 2011;95(1):50–60, e1–15.

    Article  CAS  PubMed  Google Scholar 

  42. Neves AR, Devesa M, Martinez F, Garcia-Martinez S, Rodriguez I, Polyzos NP, et al. What is the clinical impact of the endometrial receptivity array in PGT-A and oocyte donation cycles? J Assist Reprod Genet. 2019;36(9):1901–8.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Cozzolino M, Diaz-Gimeno P, Pellicer A, Garrido N. Evaluation of the endometrial receptivity assay and the preimplantation genetic test for aneuploidy in overcoming recurrent implantation failure. J Assist Reprod Genet. 2020;37(12):2989–97.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Tan J, Kan A, Hitkari J, Taylor B, Tallon N, Warraich G, et al. The role of the endometrial receptivity array (ERA) in patients who have failed euploid embryo transfers. J Assist Reprod Genet. 2018;35(4):683–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Claine E, Devine K. Endometrial receptivity, to test or not to test: the evidence on contemporary assays. Fertil Steril Rev. 2023;4:50–65.

    Google Scholar 

  46. Yoshioka S, Fujiwara H, Nakayama T, Kosaka K, Mori T, Fujii S. Intrauterine administration of autologous peripheral blood mononuclear cells promotes implantation rates in patients with repeated failure of IVF-embryo transfer. Hum Reprod. 2006;21(12):3290–4.

    Article  CAS  PubMed  Google Scholar 

  47. Yu N, Zhang B, Xu M, Wang S, Liu R, Wu J, et al. Intrauterine administration of autologous peripheral blood mononuclear cells (PBMCs) activated by HCG improves the implantation and pregnancy rates in patients with repeated implantation failure: a prospective randomized study. Am J Reprod Immunol. 2016;76(3):212–6.

    Article  CAS  PubMed  Google Scholar 

  48. Busnelli A, Somigliana E, Cirillo F, Baggiani A, Levi-Setti PE. Efficacy of therapies and interventions for repeated embryo implantation failure: a systematic review and meta-analysis. Sci Rep. 2021;11(1):1747.

    Article  CAS  PubMed  PubMed Central  ADS  Google Scholar 

  49. Dawood AS, Salem HA. Current clinical applications of platelet-rich plasma in various gynecological disorders: an appraisal of theory and practice. Clin Exp Reprod Med. 2018;45(2):67–74.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Nazari L, Salehpour S, Hoseini S, Zadehmodarres S, Ajori L. Effects of autologous platelet-rich plasma on implantation and pregnancy in repeated implantation failure: a pilot study. Int J Reprod Biomed. 2016;14(10):625–8.

    PubMed  PubMed Central  Google Scholar 

  51. Nazari L, Salehpour S, Hosseini S, Sheibani S, Hosseinirad H. The effects of autologous platelet-rich plasma on pregnancy outcomes in repeated implantation failure patients undergoing frozen embryo transfer: a randomized controlled trial. Reprod Sci. 2022;29(3):993–1000.

    Article  CAS  PubMed  Google Scholar 

  52. Akbarzadeh S, Layton JE. Granulocyte colony-stimulating factor receptor: structure and function. Vitam Horm. 2001;63:159–94.

    Article  CAS  PubMed  Google Scholar 

  53. Davari-Tanha F, Shahrokh Tehraninejad E, Ghazi M, Shahraki Z. The role of G-CSF in recurrent implantation failure: a randomized double blind placebo control trial. Int J Reprod Biomed. 2016;14(12):737–42.

    PubMed  PubMed Central  Google Scholar 

  54. Aleyasin A, Abediasl Z, Nazari A, Sheikh M. Granulocyte colony-stimulating factor in repeated IVF failure, a randomized trial. Reproduction. 2016;151(6):637–42.

    Article  CAS  PubMed  Google Scholar 

  55. Dieamant F, Vagnini LD, Petersen CG, Mauri AL, Renzi A, Petersen B, et al. New therapeutic protocol for improvement of endometrial receptivity (PRIMER) for patients with recurrent implantation failure (RIF) - a pilot study. JBRA Assist Reprod. 2019;23(3):250–4.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Reproductive Endocrinology and Infertility, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Vermont Medical Center, 111 Colchester Avenue, Burlington, VT, 05401, USA

    Catherine Boniface & Navid Esfandiari

Authors
  1. Catherine Boniface
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Navid Esfandiari
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

CB wrote the draft and NE reviewed and finalized the manuscript.

Corresponding author

Correspondence to Navid Esfandiari.

Ethics declarations

Conflict of Interest

The authors declare no competing interests.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Boniface, C., Esfandiari, N. Immunology Updates in Recurrent Implantation Failure in In Vitro Fertilization. Curr Obstet Gynecol Rep 13, 16–23 (2024). https://doi.org/10.1007/s13669-024-00375-0

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13669-024-00375-0

Keywords

Search

Navigation